Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review. | Cancers (Basel) | 2023 | 36900159 | PubTator, text mining | PubMed |
| Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. | Cells | 2023 | 36899946 | PubTator, text mining | PubMed |
| microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation. | Front Cardiovasc Med | 2023 | 36895835 | PubTator, text mining | PubMed |
| Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications. | Front Neurosci | 2023 | 36895420 | PubTator, text mining | PubMed |
| MiR-760 targets HBEGF to control cartilage extracellular matrix degradation in osteoarthritis. | J Orthop Surg Res | 2023 | 36894989 | PubTator, text mining | PubMed |
| A prediction model for predicting the risk of acute respiratory distress syndrome in sepsis patients: a retrospective cohort study. | BMC Pulm Med | 2023 | 36890503 | PubTator, text mining | PubMed |
| Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma. | Cureus | 2023 | 36883085 | PubTator, text mining | PubMed |
| RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis. | Front Neurosci | 2023 | 36875672 | PubTator, text mining | PubMed |
| The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines. | Front Oncol | 2023 | 36874116 | PubTator, text mining | PubMed |
| 3D genome-selected microRNAs to improve Alzheimer's disease prediction. | Front Neurol | 2023 | 36860572 | PubTator, text mining | PubMed |
| The role of microRNAs in the molecular link between circadian rhythm and autism spectrum disorder. | Anim Cells Syst (Seoul) | 2023 | 36860270 | PubTator, text mining | PubMed |
| miRNA Signature of Urine Extracellular Vesicles Shows the Involvement of Inflammatory and Apoptotic Processes in Diabetic Chronic Kidney Disease. | Pharm Res | 2023 | 36859746 | PubTator, text mining | PubMed |
| Unfolding of Imminent Bio-Signatures in the Prognosis of Thyroid Cancer; The Emergence of Estrogen Related Receptor Gamma (ERRγ) as a Hurricane. | Asian Pac J Cancer Prev | 2023 | 36853284 | PubTator, text mining | PubMed |
| Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer. | Aging (Albany NY) | 2023 | 36849137 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments. | Stroke | 2023 | 36848419 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives. | Pharmaceutics | 2023 | 36839827 | PubTator, text mining | PubMed |
| Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products. | Int J Mol Sci | 2023 | 36835100 | PubTator, text mining | PubMed |
| Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders. | Int J Mol Sci | 2023 | 36834733 | PubTator, text mining | PubMed |
| Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia. | Genes (Basel) | 2023 | 36833173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=23